{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:40:50Z","timestamp":1786995650490,"version":"build-2736575974"},"reference-count":114,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.pharmthera.2012.08.002","type":"journal-article","created":{"date-parts":[[2012,8,4]],"date-time":"2012-08-04T09:48:12Z","timestamp":1344073692000},"page":"175-185","source":"Crossref","is-referenced-by-count":65,"title":["Oxidative stress and macrophage foam cell formation during diabetes mellitus\u2010induced atherogenesis: Role of insulin therapy"],"prefix":"10.1016","volume":"136","author":[{"given":"Marielle","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Aviram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Hayek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2012.08.002_bb0005","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1161\/01.CIR.99.17.2239","article-title":"Effect of diabetes mellitus on formation of coronary collateral vessels","volume":"99","author":"Abaci","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0010","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1161\/01.ATV.15.11.1812","article-title":"Serum paraoxonase activity, concentration and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoprotein","volume":"11","author":"Abbott","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0015","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2174\/1389450054021990","article-title":"Molecular targets of diabetic cardiovascular complications","volume":"6","author":"Ahmad","year":"2005","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.athoracsur.2008.03.046","article-title":"High-dose insulin therapy attenuates systemic inflammatory response in coronary artery bypass grafting patients","volume":"86","author":"Albacker","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0026-0495(00)91039-4","article-title":"Effect of insulin on human aortic endothelial nitric oxide synthase","volume":"49","author":"Aljada","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0030","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1210\/jc.86.1.450","article-title":"Insulin inhibits NF-kappaB and MCP-1 expression in human aortic endothelial cells","volume":"86","author":"Aljada","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2012.08.002_bb0035","doi-asserted-by":"crossref","first-page":"s36","DOI":"10.2337\/diacare.27.2007.S36","article-title":"Nutrition Principles and Recommendations in Diabetes","volume":"27","author":"American Diabetes Association","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0040","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(01)05415-0","article-title":"Type 1 diabetes: New perspectives on disease pathogenesis and treatment","volume":"358","author":"Atkinson","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0065","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1089\/ars.1999.1.4-585","article-title":"Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins","volume":"1","author":"Aviram","year":"1999","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0045","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/ajcn\/71.5.1062","article-title":"Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: Studies in humans and in atherosclerotic apolipoprotein E-deficient mice","volume":"71","author":"Aviram","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0050","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1749-6632.2002.tb02913.x","article-title":"Wine flavonoids protect against LDL oxidation and atherosclerosis","volume":"957","author":"Aviram","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0055","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.freeradbiomed.2004.06.030","article-title":"Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development","volume":"37","author":"Aviram","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0060","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.mol.0000174398.84185.0f","article-title":"Paraoxonases and cardiovascular diseases: pharmacological and nutritional influences","volume":"16","author":"Aviram","year":"2005","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0070","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/MOL.0b013e32832b7167","article-title":"Hyperlipidaemia and cardiovascular disease: Inflammation andoxidative stress in diabetic patients","volume":"20","author":"Aviram","year":"2009","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0075","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.freeradbiomed.2007.12.021","article-title":"Oxidative stress and vascular disease in diabetes: Is the dichotomization of insulin signaling still valid?","volume":"44","author":"Avogaro","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0080","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.cardiores.2004.05.001","article-title":"Advanced end products and vascular inflammation: Implications for accelerated atherosclerosis in diabetes","volume":"63","author":"Basta","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0085","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2217\/pgs.10.17","article-title":"Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2\u20132 genotype","volume":"11","author":"Blum","year":"2010","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0090","doi-asserted-by":"crossref","first-page":"E581","DOI":"10.1152\/ajpendo.90437.2008","article-title":"Phosphorylation of IRS proteins, insulin action, and insulin resistance","volume":"296","author":"Boura-Halfon","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0100","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)80213-5","article-title":"The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor","volume":"89","author":"Brown","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0095","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1161\/hq1001.096640","article-title":"Insulin inhibits the maturation phase of VLDL assembly via a phosphoinositide 3-kinase-mediated event","volume":"21","author":"Brown","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0105","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry of and molecular biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0110","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0115","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2174\/1874467211104030154","article-title":"Excess exposure to insulin is the primary cause of insulin resistance and its associated atherosclerosis","volume":"4","author":"Cao","year":"2011","journal-title":"Curr Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0120","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/01.CIR.100.8.820","article-title":"Insulin stimulates both endothelin and nitric oxide activity in the human forearm","volume":"100","author":"Cardillo","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0125","doi-asserted-by":"crossref","first-page":"III2","DOI":"10.1161\/01.CIR.0000131511.50734.44","article-title":"Atherogenic lipoprotein particles in atherosclerosis","volume":"109","author":"Carmena","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0130","doi-asserted-by":"crossref","first-page":"S232","DOI":"10.2337\/dc09-S316","article-title":"Antioxidant anti-inflammatory treatment in type 2 diabetes","volume":"32","author":"Ceriello","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0135","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.1194\/jlr.R800059-JLR200","article-title":"Diabetes and atherosclerosis: Is there a role for hyperglycemia?","volume":"50","author":"Chait","year":"2009","journal-title":"J Lipid Res"},{"issue":"Suppl. 3","key":"10.1016\/j.pharmthera.2012.08.002_bb0140","first-page":"4","article-title":"Advances in diabetes for the millennium: Vitamins and oxidant stress in diabetes and its complications","volume":"6","author":"Chertow","year":"2004","journal-title":"MedGenMed"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0145","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0006-291X(02)02140-X","article-title":"Insulin suppression of VLDL apo B secretion is not mediated by the LDL receptor","volume":"297","author":"Chirieac","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0150","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.2337\/diabetes.44.9.1059","article-title":"Acute hyperinsulinemia decreases the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM","volume":"44","author":"Cummings","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0155","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1210\/jc.86.7.3257","article-title":"Insulin inhibits intranuclear nuclear factor kappaB and stimulates I-kappaB in mononuclear cells in obese subjects: Evidence for an anti-inflammatory effect?","volume":"86","author":"Dandona","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0160","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/MCO.0b013e3281e38774","article-title":"Anti-inflammatory effects of insulin","volume":"10","author":"Dandona","year":"2007","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0165","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1056\/NEJM199604113341504","article-title":"Hyperinsulinemia as an independent risk factor for ischemic heart disease","volume":"334","author":"Despr\u00e9s","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0170","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0175","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1172\/JCI23354","article-title":"Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation","volume":"116","author":"Du","year":"2006","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.002_bb0180","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s001250050004","article-title":"Significant improvement of apolipoprotein B-containing lipoprotein metabolism by insulin treatment in patients with non-insulin-dependent diabetes mellitus","volume":"43","author":"Duvillard","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0185","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/er.2001-0039","article-title":"Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes","volume":"23","author":"Evans","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0190","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diabetes.38.2.141","article-title":"Importance of small intestine in diabetic hypercholesterolemia","volume":"38","author":"Feingold","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0195","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1136\/hrt.2003.018622","article-title":"Diabetes and atherogenesis","volume":"90","author":"Fisher","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0200","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.bbrc.2009.11.091","article-title":"High glucose stimulates macrophage SR-BI expression and induces a switch in its activity from cholesterol efflux to cholesterol influx","volume":"391","author":"Gantman","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0205","doi-asserted-by":"crossref","first-page":"34327","DOI":"10.1074\/jbc.M807036200","article-title":"Selective regulation of heme oxygenase-1 expression and function by insulin through IRS1\/ phosphoinositide 3-kinase\/Akt2 pathway","volume":"283","author":"Geraldes","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0210","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0215","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1021\/jf000404a","article-title":"Antioxidant activity of pomegranate juice and its relationship with phenolics composition and processing","volume":"10","author":"Gil","year":"2000","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0220","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/204748730000700505","article-title":"The insulin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis","volume":"7","author":"Ginsberg","year":"2000","journal-title":"J Cardiovasc Risk"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0225","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1161\/01.ATV.18.11.1803","article-title":"Genotype-specific transcriptional regulation of PAI-1 gene by insulin, hypertriglyceridemic VLDL, and Lp(a) in transfected, cultured human endothelial cells","volume":"18","author":"Grenett","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0230","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/0026-0495(94)90042-6","article-title":"Effect of diabetes, insulin and glucose load on lipid peroxidation in the rat","volume":"43","author":"Habib","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0235","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.atherosclerosis.2005.02.018","article-title":"Macrophage-foam cell formation in streptozotocin-induced diabetic mice: Stimulatory effect of glucose","volume":"183","author":"Hayek","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0240","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.atherosclerosis.2006.12.026","article-title":"Macrophage NADPH oxidase activation, impaired cholesterol fluxes, and increased cholesterol biosynthesis in diabetic mice: a stimulatory role for d-glucose","volume":"195","author":"Hayek","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0245","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.freeradbiomed.2010.12.005","article-title":"Oxidative stress and the etiology of insulin resistance and type 2 diabetes","volume":"51","author":"Henriksen","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0250","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1161\/01.ATV.20.2.402","article-title":"Insulin-mediated stimulation of protein kinase Akt: A potent survival signaling cascade for endothelial cells","volume":"20","author":"Hermann","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0255","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1161\/01.RES.85.1.108","article-title":"Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions","volume":"85","author":"Hirano","year":"1999","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0260","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0265","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1172\/JCI2961","article-title":"Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2","volume":"101","author":"Horton","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0270","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/01.mol.0000226116.35555.eb","article-title":"Roles of ATP binding cassette transporters A1 and G1 scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages","volume":"17","author":"Jessup","year":"2006","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0280","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1515\/CCLM.1999.118","article-title":"Ox-LDL atherogenic and proinflammatory characteristics during macrophage foam cell formation: An inhibitory role for nutritional antioxidants and serum paraoxonase","volume":"37","author":"Kaplan","year":"1999","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0275","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/FJC.0b013e3181879d98","article-title":"High glucose concentration increases macrophage cholesterol biosynthesis in diabetes through activation of the sterol regulatory element binding protein 1 (SREBP1): Inhibitory effect of insulin","volume":"52","author":"Kaplan","year":"2008","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl. 1","key":"10.1016\/j.pharmthera.2012.08.002_bb0285","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S0168-8227(11)70024-9","article-title":"Antiatheromatic effects of insulin","volume":"93","author":"Karamitsos","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0290","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1046\/j.1432-1033.2002.03017.x","article-title":"Glycation and glycoxidation of low-density lipoproteins by glucose and low-molecular mass aldehydes. Formation of modified and oxidized particles","volume":"270","author":"Knott","year":"2003","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0295","doi-asserted-by":"crossref","first-page":"280","DOI":"10.5551\/jat.9.280","article-title":"Insulin treatment prevents LDL from accelerated oxidation in patients with diabetes","volume":"9","author":"Kondo","year":"2002","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0300","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.atherosclerosis.2011.07.119","article-title":"The antioxidant HDL-associated paraoxonase-1 (PON1) attenuates diabetes development and stimulates \u03b2-cell insulin release","volume":"219","author":"Koren-Gluzer","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0305","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1146\/annurev.biochem.68.1.523","article-title":"Charting the fate of the \u201cgood cholesterol\u201d: Identification and characterization of the high-density lipoprotein receptor SR-BI","volume":"68","author":"Krieger","year":"1999","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0310","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1172\/JCI115641","article-title":"Human cells possess a plasma membrane-bound H2O2-generating system that is activated by insulin via a mechanism bypassing the receptor kinase","volume":"89","author":"Krieger-Brauer","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0315","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1161\/01.CIR.101.6.676","article-title":"Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: A specific vascular action of insulin","volume":"101","author":"Kuboki","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0320","doi-asserted-by":"crossref","first-page":"591","DOI":"10.33549\/physiolres.930244","article-title":"Hyperinsulinemia and oxidative stress","volume":"51","author":"Kyselov\u00e1","year":"2002","journal-title":"Physiol Res"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0325","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1172\/JCI19528","article-title":"Increased CD36 protein as a response to defective insulin signaling in macrophages","volume":"113","author":"Liang","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0330","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","article-title":"Atherosclerosis","volume":"407","author":"Lusis","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0335","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2796.2005.01554.x","article-title":"The paraoxonase-2-310 polymorphism is associated with the presence of microvascular complications in diabetes mellitus","volume":"258","author":"Mackness","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0340","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s00125-004-1330-x","article-title":"Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase","volume":"47","author":"Madonna","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0345","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s001250050700","article-title":"Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM","volume":"40","author":"Malmstr\u00f6m","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0350","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/S0891-5849(03)00185-0","article-title":"Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications","volume":"34","author":"Martin-Gallan","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0360","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.2337\/db06-0723","article-title":"Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetes","volume":"55","author":"Mastorikou","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0355","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.1464-5491.2008.02546.x","article-title":"Glycation of paraoxonase 1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides","volume":"25","author":"Mastorikou","year":"2008","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.pharmthera.2012.08.002_bb0365","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1464-5491.2010.03167.x","article-title":"Banting Memorial Lecture 2010^. Type 2 diabetes as an \u2018infectious\u2019 disease: Is this the Black Death of the 21st century?","volume":"28","author":"Matthews","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0370","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0014-5793(95)00332-4","article-title":"Glucose-enriched medium enhances cell-mediated low density lipoprotein peroxidation","volume":"363","author":"Maziere","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0375","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2337\/diabetes.33.4.333","article-title":"In vivo stimulation of low-density lipoprotein degradation by insulin","volume":"33","author":"Mazzone","year":"1984","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0380","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.atherosclerosis.2009.07.057","article-title":"Paraoxonase 2 (PON2) decreases high glucose-induced macrophage triglycerides (TG) accumulation, via inhibition of NADPH-oxidase and DGAT1 activity: Studies in PON2-deficient mice","volume":"208","author":"Meilin","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0385","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/biof.144","article-title":"Insulin increases macrophage triglyceride accumulation under diabetic conditions through the down regulation of hormone sensitive lipase and adipose triglyceride lipase","volume":"37","author":"Meilin","year":"2011","journal-title":"Biofactors"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0390","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s11906-000-0074-3","article-title":"Insulin and the vasculature","volume":"2","author":"Mikhail","year":"2000","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0395","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrm2327","article-title":"Mechanisms of disease: Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes","volume":"9","author":"Muoio","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0400","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s11883-011-0165-4","article-title":"Vasculotoxic effects of insulin and its role in atherosclerosis: What is the evidence?","volume":"13","author":"Nandish","year":"2011","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0405","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.freeradbiomed.2004.09.035","article-title":"The paraoxonase gene family and atherosclerosis","volume":"38","author":"Ng","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0410","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/S0140-6736(02)09089-X","article-title":"Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: A prospective study","volume":"359","author":"Norhammar","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5551\/jat.10.1","article-title":"Advanced glycation end products (AGE) inhibit scavenger receptor class B type I-mediated reverse cholesterol transport: A new crossroad of AGE to cholesterol metabolism","volume":"10","author":"Ohgami","year":"2003","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0420","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1007\/s00125-007-0797-7","article-title":"Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: Findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC)","volume":"50","author":"Prince","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0425","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0026-0495(96)90270-X","article-title":"Insulin decreases circulating vitamin E levels in humans","volume":"45","author":"Qui\u00f1ones-Galvan","year":"1996","journal-title":"Metabolism"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0430","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1161\/01.ATV.19.12.2928","article-title":"Evidence that acute insulin administration enhances LDL cholesterol susceptibility to oxidation in healthy humans","volume":"19","author":"Qui\u00f1ones-Galvan","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0435","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.freeradbiomed.2010.12.006","article-title":"Oxidative stress, insulin signaling, and diabetes","volume":"50","author":"Rains","year":"2011","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"10.1016\/j.pharmthera.2012.08.002_bb0440","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cmet.2010.03.013","article-title":"Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice","volume":"11","author":"Rask-Madsen","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0445","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diabetes.37.12.1595","article-title":"Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0450","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00041433-200006000-00002","article-title":"Triglyceride synthesis: Insights from the cloning of diacylglycerol acyltransferase","volume":"11","author":"Robert","year":"2000","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0455","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.2337\/diabetes.46.10.1601","article-title":"Insulin and sulfonylurea therapy in NIDDM patients. Are the effects on lipoprotein metabolism different even with similar blood glucose control?","volume":"46","author":"Romano","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0460","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/biof.16","article-title":"Paraoxonases role in the prevention of cardiovascular diseases","volume":"35","author":"Rosenblat","year":"2009","journal-title":"Biofactors"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0465","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1194\/jlr.M800550-JLR200","article-title":"Paraoxonase 2 attenuates macrophage triglyceride accumulation via inhibition of diacylglycerol acyltransferase 1 (DGAT1), the rate limiting enzyme in triglyceride biosynthesis","volume":"50","author":"Rosenblat","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0470","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.atherosclerosis.2005.09.006","article-title":"Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages","volume":"187","author":"Rosenblat","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0475","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.atherosclerosis.2005.08.026","article-title":"Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: Relevance to diabetes","volume":"187","author":"Rosenblat","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0480","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.freeradbiomed.2008.02.012","article-title":"Paraoxonase 1 (PON1) attenuates diabetes development in mice through its antioxidative properties","volume":"44","author":"Rozenberg","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0485","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1074\/jbc.273.9.5196","article-title":"The microsomal triglyceride transfer protein catalyzes the post-translational assembly of apolipoprotein B-100 very low density lipoprotein in McA-RH7777 cells","volume":"273","author":"Rustaeus","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0490","doi-asserted-by":"crossref","first-page":"40236","DOI":"10.1074\/jbc.M608048200","article-title":"Adipose triglyceride lipase and hormone sensitive lipase are the major enzymes in adipose triacylglycerol catabolism","volume":"281","author":"Schwiger","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0495","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/01.ATV.0000042232.42883.56","article-title":"Oral insulin supplementation attenuates atherosclerosis progression in apolipoprotein E-deficient mice","volume":"23","author":"Shamir","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0500","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0163-7827(01)00010-8","article-title":"Sterol regulatory element binding proteins transcriptional regulators of lipid synthetic genes","volume":"40","author":"Shimano","year":"2001","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0505","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1042\/bj3130567","article-title":"Insulin-mediated inhibition of apolipoprotein B secretion requires an intracellular trafficking event and phosphatidylinositol 3-kinase activation: Studies with brefeldin A and wortmannin in primary cultures of rat hepatocytes","volume":"313","author":"Sparks","year":"1996","journal-title":"Biochem J"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0510","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.beem.2009.03.010","article-title":"The impact of glucose-lowering therapy on cardiovascular outcomes","volume":"23","author":"Standl","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0515","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1172\/JCI117433","article-title":"Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release","volume":"94","author":"Steinberg","year":"1994","journal-title":"J Clin Invest"},{"issue":"Suppl. 3","key":"10.1016\/j.pharmthera.2012.08.002_bb0520","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.2337\/diab.45.3.S45","article-title":"Hyperinsulinemia and atherosclerosis","volume":"45","author":"Stout","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0525","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2710.2009.01154.x","article-title":"Effects of vitamin E supplementation on glycaemic control in type 2 diabetes: Systematic review of randomized controlled trials","volume":"36","author":"Suksomboon","year":"2011","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0530","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2796.2007.01898.x","article-title":"Cholesterol efflux pathways and other potential mechanisms involved in the atheroprotective effect of high density lipoprotein","volume":"263","author":"Tall","year":"2008","journal-title":"J Intern Med"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0535","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1586\/erc.10.45","article-title":"Atherosclerosis, diabetes and lipoproteins","volume":"8","author":"Tomkin","year":"2010","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0540","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/01.mol.0000169351.28019.04","article-title":"Scavenger receptor BI and ATP-binding cassette transporter A1 in reverse cholesterol transport and atherosclerosis","volume":"16","author":"Van Eck","year":"2005","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0545","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.2337\/diabetes.51.10.3049","article-title":"Alpha-tocopherol decreases superoxide anion release in human monocytes under hyperglycemic conditions via inhibition of protein kinase C-alpha","volume":"51","author":"Venugopal","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0550","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1172\/JCI24819","article-title":"Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice","volume":"2005","author":"Vikramadithyan","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0555","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/MOL.0b013e3283412279","article-title":"Possible contributions of lipoproteins and cholesterol to the pathogenesis of diabetes mellitus type 2","volume":"22","author":"Von Eckardstein","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0560","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/1047-2797(95)00062-3","article-title":"The Insulin Resistance Atherosclerosis Study (IRAS) objectives, design, and recruitment results","volume":"5","author":"Wagenknecht","year":"1995","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0565","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1172\/JCI118871","article-title":"Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells","volume":"98","author":"Zeng","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2012.08.002_bb0570","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/dmrr.895","article-title":"Cellular cholesterol efflux to serum is 399 impaired in diabetic nephropathy","volume":"24","author":"Zhou","year":"2008","journal-title":"Diabetes Metab Res Rev"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725812001635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725812001635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T01:43:11Z","timestamp":1714268591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725812001635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":114,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0163725812001635"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2012.08.002","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}